Predictors of HCV Response to Treatment with Pegylated Interferon and Ribavirin in Sharkia Governorate

Background and study aim: The current standard of care (SOC) for chronic hepatitis C (CHC) in Egypt is pegylated interferon and ribavirin (PEG-INF/RBV) for 48 weeks, which is expensive, can be difficult to tolerate and with high failure rate. Additional information about predicting sustained virolog...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Sahar El-Nemr, Hala Hussein, Monkez Yousif, Mohamed Abdel-Aal, Hoda El-Hady
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Zagazig University, Faculty of Medicine, Endemic and Tropical Medicine Department 2012-03-01
Цуврал:	Afro-Egyptian Journal of Infectious and Endemic Diseases
Нөхцлүүд:	HCV PEGINF response predictors Ribavirin Pegylated interferon-α
Онлайн хандалт:	https://aeji.journals.ekb.eg/article_15415_42bdc9b8194658d83a9006087abfc96b.pdf
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!